Providing highly-skilled senior consultants for the medical industry
At Medicologic we take great pride in providing top-class consultants to the medical industry. We have shaped a range of services to fit the needs of our clients and accommodate
most potential skills and flexibility needs.
With our in-housing service you get full controll with our consultant being present at your office on a everyday-basis. Our consultants are flexible, well-liked, and very competent. We will make sure the inclusion of a new consultant to your team will go as smooth as possible – with no loss in task-management and delivery.
MDR- & IVDR-Transition
Regulus - Innovation
Outsource your strategic innovation to us.
We will set up an entire project-team for you.
The process will be controlled and developed through skilled consultants and great communication.
Make sure your company’s on-going processes and development-initiatives are kept up-to-date continuously. With a Service Agreement you have full flexibility. With a fixed weekly, monthly, or annually hour-budget, you have complete control over costs and consultants.
Know-how, skills and mindset
At Medicologic we know all about the challenges of finding talent and the right skill-sets for the tasks.
Medicologic was founded in 2000 by the present CEO Michael Funder, and through more than 20 years we have strived to find the greatest talent and the most skilled specialists for the medical device industry.
Our goal is to create the best scenarios for our clients, and combine our talent and specialists with the goals and budgets at hand.
We strive for customer-service excellence – and a part of this is providing a service, that gives our clients full flexibility to pull on our various ressources on any given time.
The expectations in the medical device market are high with increasing focus on patient safety and treatment methods.
Our team of dedicated freelance consultants and specialists help you develop solutions that meet the expectations, requirements and challenges in the medtech and pharma markets.